Balyasny Asset Management L.P.

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 1218710 Chicago, IL

Position in ACRS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$12,604,980

+$12,497,112 QoQ

Shares Held

3,361,328

+4667.7% QoQ

Ownership

2.41%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Balyasny Asset Management L.P. holds $2,162,785,356 across 177 Biotechnology names. ACRS ranks #52 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TERN	Terns Pharmaceuticals, Inc.	2,779,445	$146,532,340
2	ERAS	Erasca, Inc.	5,143,985	$83,229,677
3	TNGX	Tango Therapeutics, Inc.	3,826,659	$80,053,706
4	APLS	Apellis Pharmaceuticals, Inc.	1,917,501	$77,141,065
5	BMRN	Biomarin Pharmaceutical Inc	1,362,752	$76,981,860
6	CYTK	Cytokinetics Inc	992,545	$65,418,640
7	DAWN	Day One Biopharmaceuticals, Inc.	2,625,235	$56,285,038
8	FOLD	AMICUS THERAPEUTICS, INC.	3,827,513	$55,345,837

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,604,980	3,361,328	+4667.7%	Shares	Sole	2026-05-15
2025-03-31	$107,868	70,502	+406.8%	Shares	Sole	2025-05-15
2024-06-30	$15,301	13,910	+32.3%	Shares	Sole	2024-08-14
2023-09-30	$72,000	10,511	-48.7%	Shares	Sole	2023-11-14
2022-12-31	$322,922	20,503	-80.7%	Shares	Sole	2023-02-14
2022-09-30	$1,670,753	106,147	-49.4%	Shares	Other	2022-11-15
2022-03-31	$3,614,124	209,636	-55.1%	Shares	Sole	2022-05-16
2021-12-31	$6,781,456	466,400	+188.2%	Shares	Sole	2022-02-14
2021-09-30	$2,913,174	161,843	+4.8%	Shares	Sole	2021-12-01
2021-06-30	$2,711,615	154,420	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.